BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

373 related articles for article (PubMed ID: 34052871)

  • 1. Eosinophils and eosinophil-associated disorders: immunological, clinical, and molecular complexity.
    Valent P; Degenfeld-Schonburg L; Sadovnik I; Horny HP; Arock M; Simon HU; Reiter A; Bochner BS
    Semin Immunopathol; 2021 Jun; 43(3):423-438. PubMed ID: 34052871
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proposed refined diagnostic criteria and classification of eosinophil disorders and related syndromes.
    Valent P; Klion AD; Roufosse F; Simon D; Metzgeroth G; Leiferman KM; Schwaab J; Butterfield JH; Sperr WR; Sotlar K; Vandenberghe P; Hoermann G; Haferlach T; Moriggl R; George TI; Akin C; Bochner BS; Gotlib J; Reiter A; Horny HP; Arock M; Simon HU; Gleich GJ
    Allergy; 2023 Jan; 78(1):47-59. PubMed ID: 36207764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. World Health Organization-defined eosinophilic disorders: 2014 update on diagnosis, risk stratification, and management.
    Gotlib J
    Am J Hematol; 2014 Mar; 89(3):325-37. PubMed ID: 24577808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. World Health Organization and International Consensus Classification of eosinophilic disorders: 2024 update on diagnosis, risk stratification, and management.
    Shomali W; Gotlib J
    Am J Hematol; 2024 May; 99(5):946-968. PubMed ID: 38551368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Causes of hypereosinophilia in 100 consecutive patients.
    Moller D; Tan J; Gauiran DTV; Medvedev N; Hudoba M; Carruthers MN; Dehghan N; van den Berghe J; Bruyère H; Chen LYC
    Eur J Haematol; 2020 Sep; 105(3):292-301. PubMed ID: 32364630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypereosinophilic Syndrome.
    Curtis C; Ogbogu P
    Clin Rev Allergy Immunol; 2016 Apr; 50(2):240-51. PubMed ID: 26475367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypereosinophilic syndromes.
    Roufosse FE; Goldman M; Cogan E
    Orphanet J Rare Dis; 2007 Sep; 2():37. PubMed ID: 17848188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypereosinophilic syndrome and proliferative diseases.
    Ionescu MA; Wang L; Janin A
    Acta Dermatovenerol Croat; 2009; 17(4):323-30. PubMed ID: 20021987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Spectrum of Hypereosinophilia and Associated Clonal Disorders - A Real-World Data Based on Combined Retrospective and Prospective Analysis from a Tropical Setting.
    Sreedharanunni S; Varma N; Sachdeva MUS; Naseem S; Malhotra P; Bansal D; Trehan A; Varma S
    Mediterr J Hematol Infect Dis; 2018; 10(1):e2018052. PubMed ID: 30210745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advances in diagnosis and treatment of eosinophilia.
    Sheikh J; Weller PF
    Curr Opin Hematol; 2009 Jan; 16(1):3-8. PubMed ID: 19057198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biologic therapies for hypereosinophilic disorders: From tyrosine kinase inhibitors to monoclonal antibodies. Towards an increasingly customized management?
    Iurlo A; Cattaneo D
    Blood Rev; 2023 Mar; 58():101014. PubMed ID: 36153195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Imatinib for the treatment of hypereosinophilic syndromes.
    Helbig G
    Expert Rev Clin Immunol; 2018 Feb; 14(2):163-170. PubMed ID: 29303368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Hypereosinophilic syndromes: pathogenic and therapeutic up-to-date].
    Kahn JE; Grandpeix-Guyodo C; Ackermann F; Charles P; Legrand F; Blétry O
    Rev Med Interne; 2010 Apr; 31(4):268-76. PubMed ID: 20303627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic and therapeutic management in patients with hypereosinophilic syndromes.
    Helbig G; Kyrcz-Krzemień S
    Pol Arch Med Wewn; 2011; 121(1-2):44-52. PubMed ID: 21346698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The Hypereosinophilic Syndromes in Childhood].
    Leu T; Simon HU; Hebestreit H; Kunzmann S
    Klin Padiatr; 2015 Nov; 227(6-7):308-13. PubMed ID: 26267413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Diagnostic Work-Up of Hypereosinophilia.
    Wang SA
    Pathobiology; 2019; 86(1):39-52. PubMed ID: 29961056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hypereosinophilic syndromes].
    Groh M; Lefèvre G; Ackermann F; Étienne N; Kahn JE
    Rev Prat; 2019 Sep; 69(7):767-773. PubMed ID: 32233322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biologic Agents for the Treatment of Hypereosinophilic Syndromes.
    Kuang FL; Klion AD
    J Allergy Clin Immunol Pract; 2017; 5(6):1502-1509. PubMed ID: 29122152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hypereosinophilic syndrome--recent developments in diagnosis and treatment].
    Hellmich B; Holl-Ulrich K; Gross WL
    Dtsch Med Wochenschr; 2007 Sep; 132(37):1892-6. PubMed ID: 17823882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypereosinophilic syndromes - An enigmatic group of disorders with an intriguing clinical spectrum and challenging treatment.
    Helbig G; Klion AD
    Blood Rev; 2021 Sep; 49():100809. PubMed ID: 33714638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.